§ BIOTECHNOLOGY
USD · BiotechnologyACAD
ACADIA PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.95
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
193 increased/new, 111 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/E | 9.7 | P/B | 3.68 |
| EPS (TTM) | 2.28 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 42.9M | 5.5% | ±0% |
| BlackRock, Inc. | 21.6M | 0.0% | +4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.7M | n/a | n/a |
| State Street | 8.3M | 0.0% | +5% |
| RTW INVESTMENTS, LP | 7.1M | 1.6% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.7M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for ACAD as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER58.9% · 239 holders
PASSIVE / INDEX18.3% · 10 holders
DEALER / BANK10.0% · 30 holders
QUALITY / COMPOUNDER8.2% · 25 holders
SYSTEMATIC / QUANT2.3% · 8 holders
INCOME / DEFENSIVE1.9% · 24 holders
TACTICAL / MACRO1.3% · 5 holders
ACTIVIST0.4% · 1 holder
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ACAD in the last 180 days.